Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application.

by René Geyeregger, Christine Freimüller, Stefan Stevanovic, Julia Stemberger, Gabor Mester, Jasmin Dmytrus, Thomas Lion, Hans-Georg Rammensee, Gottfried Fischer, Britta Eiz-Vesper, Anita Lawitschka, Susanne Matthes, Gerhard Fritsch
Published 2013-01-01